These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 23210849)
1. Cantharidin as an antitumor agent: a retrospective review. Deng LP; Dong J; Cai H; Wang W Curr Med Chem; 2013; 20(2):159-66. PubMed ID: 23210849 [TBL] [Abstract][Full Text] [Related]
3. Overview of Cantharidin and its Analogues. Wang G; Dong J; Deng L Curr Med Chem; 2018; 25(17):2034-2044. PubMed ID: 28413963 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells. Yeh CB; Su CJ; Hwang JM; Chou MC Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337 [TBL] [Abstract][Full Text] [Related]
5. Medical uses of mylabris in ancient China and recent studies. Wang GS J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797 [TBL] [Abstract][Full Text] [Related]
6. Three novel cantharidin-related compounds from the Chinese blister beetle, Mylabris phalerata Pall. Nakatani T; Konishi T; Miyahara K; Noda N Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):807-9. PubMed ID: 15256700 [TBL] [Abstract][Full Text] [Related]
7. [A study of antitumor chemotherapeutic agents -synthesis of cantharidine derivatives (author's transl)]. Liu JY; Zhang BX; Li RX Yao Xue Xue Bao; 1980 May; 15(5):271-7. PubMed ID: 7006314 [No Abstract] [Full Text] [Related]
8. N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model. Chang MC; Tsai ET; Wu JY; Liao HF; Chen YJ; Kuo CD Anticancer Drugs; 2015 Jun; 26(5):508-17. PubMed ID: 25588161 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge. Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915 [TBL] [Abstract][Full Text] [Related]
10. The effects of cantharidin and cantharidin derivates on tumour cells. Liu D; Chen Z Anticancer Agents Med Chem; 2009 May; 9(4):392-6. PubMed ID: 19442040 [TBL] [Abstract][Full Text] [Related]
11. Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways. Naz F; Wu Y; Zhang N; Yang Z; Yu C Molecules; 2020 Jul; 25(14):. PubMed ID: 32707651 [TBL] [Abstract][Full Text] [Related]
12. Cantharidin-mediated ultrastructural and biochemical changes in mitochondria lead to apoptosis and necrosis in murine Dalton's lymphoma. Prasad SB; Verma AK Microsc Microanal; 2013 Dec; 19(6):1377-94. PubMed ID: 24029497 [TBL] [Abstract][Full Text] [Related]
13. [The antitumor effect and a pharmacological study of disodium cantharidate (author's transl)]. Fu NW; Zhang LS; Quan LP Zhonghua Zhong Liu Za Zhi; 1980; 2(2):96-100. PubMed ID: 7418606 [No Abstract] [Full Text] [Related]
14. Antitumor effect of blister beetles: an ethno-medicinal practice in Karbi community and its experimental evaluation against a murine malignant tumor model. Verma AK; Prasad SB J Ethnopharmacol; 2013 Jul; 148(3):869-79. PubMed ID: 23707211 [TBL] [Abstract][Full Text] [Related]
15. Cantharis by photosynthetic bacteria biotransformation: Reduced toxicity and improved antitumor efficacy. Yu M; Zhao Y J Ethnopharmacol; 2016 Jun; 186():151-158. PubMed ID: 27041400 [TBL] [Abstract][Full Text] [Related]
16. [Studies on antitumor chemotherapeutic agents. II. Synthesis of cantharidine derivatives and analogues]. Liu JY; Zhang BX; Sun JL Yao Xue Xue Bao; 1983 Oct; 18(10):752-9. PubMed ID: 6677030 [No Abstract] [Full Text] [Related]
17. The effects of cantharidin analogues on xanthine oxidase. Tsauer W; Lin JG; Lin PY; Hsu FL; Chiang HC Anticancer Res; 1997; 17(3C):2095-8. PubMed ID: 9216670 [TBL] [Abstract][Full Text] [Related]
18. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition. Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735 [TBL] [Abstract][Full Text] [Related]
19. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design? McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882 [TBL] [Abstract][Full Text] [Related]
20. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]